How much cash does Aura Biosciences, Inc. generate?

Aura Biosciences, Inc. (AURA) generated -$91.3M in operating cash flow over the trailing twelve months.

What is Aura Biosciences, Inc.'s free cash flow?

After $362.0K of capital expenditures, Aura Biosciences, Inc.'s free cash flow was -$91.6M over the trailing twelve months, down 14.5% year over year.

Where does Aura Biosciences, Inc.'s cash flow data come from?

Every line is extracted from Aura Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Aura Biosciences, Inc. AURA Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	-$112.39M-5.8%	-$106.19M+0.3%	-$106.47M-5.0%	-$101.38M-7.1%	-$94.7M-8.9%
Depreciation and amortization	$1.15M-1.5%	$1.16M-1.6%	$1.18M0.0%	$1.18M0.0%	$1.18M-1.3%
Stock-based compensation	$14.63M+2.2%	$14.32M+2.5%	$13.97M+7.2%	$13.03M+5.7%	$12.33M+5.2%
Change in accounts payable	——	——	——	-$19K-112%	$161K-66.6%
Change in accrued liabilities	$3.99M-6.3%	$4.26M—	——	——	——
Change in other assets	——	——	——	——	-$453K-5,133%
Change in operating lease liabilities	-$1.45M-4.4%	-$1.39M-4.7%	-$1.33M-36.8%	-$972K-5.0%	-$926K-10.5%
Net cash from operating activities	-$91.28M-7.7%	-$84.74M+3.9%	-$88.23M-5.8%	-$83.35M-5.9%	-$78.71M+1.4%
Capital expenditures	$362K-19.0%	$447K-21.6%	$570K-34.2%	$866K-35.9%	$1.35M+7.9%
Net cash from investing activities	——	——	——	$89.37M+0.2%	$89.24M+29.7%
Proceeds from issuance of common stock	——	——	——	$46.52M+29,541%	-$158K—
Net cash from financing activities	$77.36M+0.3%	$77.16M+3.0%	$74.93M+5.1%	$71.28M+4,857%	$1.44M-9.8%
Effect of exchange rate changes on cash	-$201K-3.1%	-$195K-457%	-$35K-66.7%	-$21K0.0%	-$21K—
Net increase (decrease) in cash	——	——	——	——	——
Depreciation	$1.15M-1.5%	$1.16M-1.6%	$1.18M0.0%	$1.18M0.0%	$1.18M-1.3%
Gain on termination of lease	——	——	——	——	——
Operating lease liabilities	-$1.45M-4.4%	-$1.39M-4.7%	-$1.33M-36.8%	-$972K-5.0%	-$926K-10.5%
Prepaid expenses and other current assets	——	——	——	——	——
Non Cash Lease Expense	$1.59M+2.5%	$1.55M+2.4%	$1.51M-0.3%	$1.52M+1.5%	$1.5M+1.4%
Other Non Cash Items	——	——	——	——	$23.25K+565%
Net proceeds from sales of subsidiary shares	——	——	——	——	——
Proceeds from issuance of common stock relating to employee stock plans	——	——	——	——	——
Proceeds From Warrant Exercises	——	——	——	——	——
Accrued payables for capital expenditures	$111K+22.0%	$91K—	——	——	——
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations	-$201K-3.1%	-$195K-457%	-$35K-66.7%	-$21K0.0%	-$21K—
Increase Decrease In Operating Lease Liability	-$1.45M-4.4%	-$1.39M-4.7%	-$1.33M-36.8%	-$972K-5.0%	-$926K-10.5%
Proceeds From Issuance Of Warrants	——	$14.16M+33.3%	$10.62M+50.0%	$7.08M—	——
Free cash flow	-$91.64M-7.6%	-$85.19M+4.1%	-$88.8M-5.4%	-$84.22M-5.2%	-$80.06M+1.2%
Free cash flow	-$91.64M-7.6%	-$85.19M+4.1%	-$88.8M-5.4%	-$84.22M-5.2%	-$80.06M+1.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Aura Biosciences, Inc. generate?: Aura Biosciences, Inc. (AURA) generated -$91.3M in operating cash flow over the trailing twelve months.
What is Aura Biosciences, Inc.'s free cash flow?: After $362.0K of capital expenditures, Aura Biosciences, Inc.'s free cash flow was -$91.6M over the trailing twelve months, down 14.5% year over year.
Where does Aura Biosciences, Inc.'s cash flow data come from?: Every line is extracted from Aura Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.